Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply constraints.

drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply as it sees continued high demand. Instead of a preloaded injector pen, patients will ...

Eli Lilly is launching singe-use vials of its popular weight-loss drug Zepbound, which will be half the price of previous versions of the drug. The traditional injector pens are more difficult to ...

Eli Lilly has slashed the prices of starter doses of Zepbound to “significantly” expand the supply of the popular weight loss drug amid high demand in the United States. Single-dose vials ...

The low doses are also available with an auto-injector pen, but at a higher price than the vials. Eli Lilly said this new product will help with supply chain issues and increase access for those ...

Eli Lilly is expanding the supply of its weight-loss drug and selling it for half the price of other drugs in the highly lucrative market. Eli Lilly announced on Tuesday that it is now offering ...

Eli Lilly & Co. LLY said Tuesday that patients can now access 2.5- and 5-milligram single-dose vials of its weight-loss treatment Zepbound with an on-label prescription at a discount of at least ...

Eli Lilly (NYSE: LLY) offers investors the same thing as many other big pharma companies: a certain level of security when it comes to revenue. Since people need their medicines regardless of the ...

Eli Lilly and Company’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The stock has also outperformed the sector as well as the S&P 500 as seen in ...